FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$439M
This Quarter Return
+1.89%
1 Year Return
+25.58%
3 Year Return
+78.33%
5 Year Return
+134.68%
10 Year Return
+224.6%
AUM
$421M
AUM Growth
-$97M
(-19%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-24.84%
Top 10 Holdings %
Top 10 Hldgs %
40.42%
Holding
78
New
4
Increased
9
Reduced
51
Closed
7
Top Buys
| 1 |
Aon
AON
|
$11.4M |
| 2 |
PepsiCo
PEP
|
$6.16M |
| 3 |
Novartis
NVS
|
$6.07M |
| 4 |
British American Tobacco
BTI
|
$4.72M |
| 5 |
Novo Nordisk
NVO
|
$3.37M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$26.3M |
| 2 |
Microsoft
MSFT
|
$7.14M |
| 3 |
Bunge Global
BG
|
$6.2M |
| 4 |
Union Pacific
UNP
|
$5.24M |
| 5 |
Medtronic
MDT
|
$4.79M |
Sector Composition
| 1 | Healthcare | 26.36% |
| 2 | Technology | 15.78% |
| 3 | Industrials | 13.89% |
| 4 | Financials | 12.97% |
| 5 | Consumer Staples | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
PPL Corp
PPL
$26.8B
| – | – |
-70,949
| Closed | -$2.45M |
|
77
Sumitomo Mitsui Financial
SMFG
$103B
| – | – |
-473,088
| Closed | -$3.19M |
|
|
78
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-572,656
| Closed | -$26.3M |
|